Home › Funds › Franklin Resources › NAMS
Franklin Resources position in NAMS
NEWAMSTERDAM PHARMA COMPANY · Health Care
Latest position (Q2 2026)993.92K sh
Reported value held$33.68M
Portfolio Weight0.01%
First reportedQ1 2025
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 255.91K | $5.24M | New |
| Q2 2025 | 334.21K | $6.05M | Add |
| Q3 2025 | 405.82K | $11.54M | Add |
| Q4 2025 | 769.12K | $26.98M | Add |
| Q1 2026 | 770.16K | $24.65M | Hold |
| Q2 2026 | 993.92K | $33.68M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding NAMS
- Capital World Investors 12.23M sh · $414.49M · Q2 2026
- Fidelity Management & Research (FMR) 10.34M sh · $350.41M · Q2 2026
- Viking Global Investors 4.20M sh · $142.46M · Q2 2026
- Maverick Capital 3.27M sh · $110.75M · Q2 2026
- Janus Henderson Group 2.26M sh · $72.25M · Q1 2026
- Goldman Sachs Group 1.56M sh · $52.93M · Q2 2026
- JPMorgan Chase & Co 1.13M sh · $38.37M · Q2 2026
- BlackRock Inc 1.06M sh · $36.05M · Q2 2026
- Bank of America Corp 735.48K sh · $24.93M · Q2 2026
- Citadel Advisors 684.21K sh · $23.19M · Q2 2026
- Morgan Stanley 575.83K sh · $19.51M · Q2 2026